Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: Mac S. Giballa who wrote (236)	3/19/1998 9:19:00 AM
From: Bill Tomko	Respond to of 318

I agree I think it will open in the $5.00's . I spoke with the company last night and there is some hope yet that the Action II can be saved/modified. They( altn and GNE ) are trying to schedule a meeting with the FDA ASAP to discuss the unblinded findings and where to go from here. They will not be making any news releases until they meet with FDA. I believe the outcome of this FDA meeting and how GNE reacts is critical. a press release from GNE to the effect they are staying in place would be extremly helpful. Per altn gne has been fully involved with the cinical reviews and to date has been very supportive. At this point let just buckel the seat belt and see what happens.